There are 169 resources available
8P - Factors associated with primary progression in patients with advanced urothelial carcinoma (aUC) treated with enfortumab vedotin (EV): Analysis of the UNITE study
Presenter: Tanya Jindal
Session: Cocktail and Poster Display session
Resources:
Abstract
9P - The efficacy of HIF-1 alpha expression in the response to first-line standard chemotherapy and bevacizumab treatment in patients diagnosed with metastatic cervical cancer
Presenter: Hasan Yildirim
Session: Cocktail and Poster Display session
Resources:
Abstract
10P - Treatment of vaginal cancer by suppression of inhibitory receptors of CD8 T cell in mouse model
Presenter: Dong Choon Park
Session: Cocktail and Poster Display session
Resources:
Abstract
11P - snRNP200 reactive antibodies isolated from multiple AML patients show promise for targeted therapy
Presenter: Sebastian Baumann
Session: Cocktail and Poster Display session
Resources:
Abstract
12P - KBA1413, an antibody derived from a cured AML patient, recognizes a unique CD43 glycoform shared by AML, MDS and solid cancer cells
Presenter: Vanessa Clerico Mosina
Session: Cocktail and Poster Display session
Resources:
Abstract
13P - Raising anti-MUC-1 antibodies with a novel immunization platform based on the African trypanosome
Presenter: Anastasia Gkeka
Session: Cocktail and Poster Display session
Resources:
Abstract
14P - Kling-Select and Kling-Evolve: A universal platform interrogating blood and tumor-associated B cell repertoires enabling unbiased discovery of therapeutic targets and antibodies from patients
Presenter: Casper Marsman
Session: Cocktail and Poster Display session
Resources:
Abstract
16P - VIO-01, a pan-DDR DNA decoy triggering DNA repair abrogation and an enhanced antitumor immune response
Presenter: Wael Jdey
Session: Cocktail and Poster Display session
Resources:
Abstract
17P - Homologous recombination deficiency status in consecutive tumor biopsies in late-stage cancer patients
Presenter: Rosa Damkjær Britton
Session: Cocktail and Poster Display session
Resources:
Abstract
18P - NEK1 is a novel cancer target driving tumor growth through altered immune signaling
Presenter: Maria Victoria Ruiz Perez
Session: Cocktail and Poster Display session
Resources:
Abstract